Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.135 USD | -2.19% | -3.10% | -23.71% |
Jun. 03 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
Jun. 03 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- Transcripts